Longboard Pharmaceuticals, Inc entered into a Non-Voting Common Stock Purchase Agreement and issued 2,850,000 shares of its non-voting common stock to the Investor at a purchase price of $21 per share, for aggregate gross proceeds of $59,850,000 on March 26, 2024. The transaction included participation from returning investor, Farallon Capital Management, L.L.C.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.14 USD | -3.38% | -0.86% | +234.58% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+234.58% | 810M | |
+8.26% | 115B | |
+13.10% | 107B | |
-12.80% | 22.31B | |
-3.99% | 21.6B | |
-6.43% | 18.23B | |
-39.93% | 17.62B | |
+7.01% | 14.26B | |
+33.82% | 12.37B | |
-28.32% | 8.28B |
- Stock Market
- Equities
- LBPH Stock
- News Longboard Pharmaceuticals, Inc.
- Longboard Pharmaceuticals, Inc. announced that it has received $59.85 million in funding